Results 201 to 210 of about 13,458,251 (352)

An Exploratory Research to Evaluate the 30 Most Common Pulmonary Embolism Drugs in the Food and Drug Administration Adverse Event Reporting System

open access: yesThe Clinical Respiratory Journal, Volume 19, Issue 6, June 2025.
ABSTRACT Backgrounds Pulmonary embolism (PE) is a common disease and a common cause of death. However, it is currently unclear which clinically common drugs can lead to PE. Methods We collected, organized, and analyzed reports from the first quarter of 2018 to the fourth quarter of 2022.
Hang Chen   +11 more
wiley   +1 more source

‘Nobody Has Ever Spoken to Me About PCD and Fertility Issues’: Fertility Experiences of People With Primary Ciliary Dyskinesia and Their Family Caregivers

open access: yesHealth Expectations, Volume 28, Issue 3, June 2025.
ABSTRACT Background Primary ciliary dyskinesia (PCD) affects fertility in both females and males. To understand the impact and concerns among people with PCD and parents of affected children (family caregivers), we explored how they report their experiences with fertility.
Leonie D. Schreck   +9 more
wiley   +1 more source

Impact of sulfonamide allergy label on clinical outcomes of acute cystitis: a retrospective matched cohort study

open access: yesInternal Medicine Journal, Volume 55, Issue 6, Page 993-1000, June 2025.
Abstract Background Cystitis is a common infection in an otherwise healthy individual. Sulfonamide antibiotics are first‐line treatment options. Sulfonamide allergy label (SAL) is the second most common antibiotic allergy label in electronic health records, yet its impact on clinical outcomes in patients with cystitis is not well‐characterised.
Ray Moussa   +3 more
wiley   +1 more source

Evaluation of a Microtiter Latex Agglutination Test for Histoplasmosis [PDF]

open access: gold, 1972
Jay D. Gerber   +2 more
openalex   +1 more source

Home - About - Disclaimer - Privacy